DOSING REGIMENS FOR ECHINOCANDIN CLASS COMPOUNDS Russian patent published in 2020 - IPC A61K38/12 A61P31/10 

Abstract RU 2719579 C2

FIELD: medicine.

SUBSTANCE: group of inventions can be used for treating fungal infection. That is ensured by administering a compound according to claim 1

or a pharmaceutically acceptable salt thereof in a dose of saturation or one or more maintenance doses of the compound of claim 1 or a pharmaceutically acceptable salt thereof, wherein each of said doses is administered in an amount sufficient for treating fungal infection. Also provided are a dosage form for injection in single-dose or multi-dose containers in form of an aqueous solution or a lyophilized composition for reduction, comprising a compound of claim 1 or a pharmaceutically acceptable salt thereof, and an apparatus for injecting an aqueous solution of the compound of claim 1 or a pharmaceutically acceptable salt thereof, comprising container containing 0.05 to 10 ml of an aqueous solution comprising a compound of claim 1 or a pharmaceutically acceptable salt thereof, and a needle.

EFFECT: group of inventions enables effective treatment of a fungal infection with less frequent dosing ensured by the stability of the compound.

26 cl, 22 dwg, 14 tbl, 13 ex

Similar patents RU2719579C2

Title Year Author Number
DOSING MODES FOR ECHINOCANDINE CLASS COMPOUNDS 2013
  • Radhakrishnan Balasingam
  • James Kenneth Duke
  • Vaidya Anuradha
  • Polowy Karen
RU2639483C2
PERORAL COMPOSITIONS CONTAINING ESTER 17- HYDROXYPROHESTERON, AND CORRESPONDING METHODS 2012
  • Giliyar Chandrashekar
  • Venkateshvaran Srinivansan
  • Chikmas Basavaraj
  • Nachaegari Satish Kumar
  • Nachiappan Chidambaram
  • Patel Makhesh V.
RU2640912C2
COMBINED THERAPY FOR IMMUNE DISEASE TREATMENT 2004
  • Dzhost-Prajs Ehdvard Rojdon
  • Brehsher Brehdli B.
  • Chehppel Todd V.
  • Manivasakam Palanijandi
  • Saks Noa
  • Smit Brendan
  • Auspitts Bendzhamin A.
RU2329037C2
ORAL PHARMACEUTICAL COMPOSITIONS COMPRISING TAXANES AND METHODS FOR TREATMENT USING THEREOF 1999
  • Gut'Erres-Rokka Khose S.
  • Kakase Janis L.
  • Selim Sami
  • Testman Robert
  • Rutledzh Dzh. Majkl
RU2236226C2
COMPOSITIONS AND METHODS FOR APOLIPOPROTEIN C-III (APOC3) GENE EXPRESSION INHIBITION 2012
  • Bettenkort Brajan
  • Fittszherald Kevin
  • Milstejn Styuart
  • Majer Martin
  • Kharisse Klaus
  • Radzhiv Kallantkhottatkhil
  • Kuchimanchi Satiya
  • Manokharan Mutkhiakh
  • Nguejn Tujen
RU2631805C2
CYSTATHIONINE-G-LYASE (CSE) INHIBITORS 2013
  • Duron Sergio G.
  • Chapman Justin
  • Sydserff Simon G.
  • Rao Srinivas G.
  • Stein Gregory
RU2640418C2
INHALATION DOSAGE FORM OF RAPAMYCIN FOR TREATING PULMONARY HYPERTENSION 2015
  • Armer Tomas
  • Melvin Lourens S., Ml.
  • Rotberg Dzhonatan M.
  • Likhenshtejn Khenri
RU2732908C2
FORMULATIONS FOR ORAL ADMINISTRATION OF DRUG PREPARATIONS AND RELATED METHODS 2008
  • Vasan Kishor M.
  • Vasan Ehllen K.
RU2485975C2
ORAL ADMINISTRATION OF UNSTABLE OR POORLY ABSORBED DRUGS 2015
  • Yang, Yu-Tsai
  • Wang, Jong-Jing
  • Hsu, Pei-Jing
  • Chang, Li-Chien
  • Hao, Wei-Hua
  • Hsu, Chahg-Shan
RU2746548C2
ANTIFUNGAL AGENTS 2015
  • Sajbli Grekhem Edvard Morris
  • Lo Derek
  • Oliver Dzhejson Devid
  • Berch Majkl
RU2727520C2

RU 2 719 579 C2

Authors

Radhakrishnan Balasingam

James Kenneth Duke

Vaidya Anuradha

Polowy Karen

Dates

2020-04-21Published

2013-03-14Filed